Amicus Therapeutics Inc (FOLD)

SG&A Expense Growth

30.04%

Quarterly · Period ending:

FOLD logo

FOLD SG&A Expense Growth

Latest reported30.04%
FOLD Quarterly SG&A Growth (QoQ) (0.00% → 30.04%)
High-resolution chart · PNG

FOLD sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Amicus Therapeutics Inc SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
30.038%
6.4973%
-7.9323%
5.9526%
15.3942%
2.0795%
-16.4185%
25.3278%
6.9885%
0.3485%
-11.5391%
36.266%
14.8122%
-11.4408%
-8.1509%
0.8941%
24.929%
9.0619%
-9.5236%
6.9612%
15.4161%
9.2131%
-13.8207%
-7.1247%
9.123%
-6.8063%
-3.8936%
-69.6066%
357.4168%
9.2383%
6.4827%
-4.1461%
32.0322%
12.0967%
0.9356%
2.4142%
6.938%
-9.487%
22.9221%
-8.6726%
11.8397%
85.697%
28.8004%
16.4734%
4.7059%
10.8773%
-8.1723%
12.3996%
-0.6472%
-4.0373%
0.1451%
8.2604%
-10.8108%
-14.1605%
42.1001%
4.5443%
-19.087%
-27.9613%
52.6579%
15.1452%
-1.7729%
-3.1841%
2.4204%
-9.5205%
-16.8488%
-0.1149%
0.539%
4.1082%
14.1615%
-14.5955%
-1.3112%
-1.8547%
33.6368%
23.9887%
11.8947%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.